Last update 21 Nov 2024

Methenamine Hippurate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane, HMT, HMTA
+ [11]
Target-
Mechanism-
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (05 Jul 1967),
Regulation-
Login to view timeline

Structure

Molecular FormulaC15H21N5O3
InChIKeyROAIXOJGRFKICW-UHFFFAOYSA-N
CAS Registry5714-73-8

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Urinary Tract Infections
US
09 Sep 1976
Infectious Diseases
US
05 Jul 1967
Lower Urinary Tract Symptoms
CN
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
185
(Methenamine Hippurate With Cranberry)
lbvtwzyopj(jifbiogeyc) = tfqhpsyobj dnrdtklazi (uvbfqferct, sulkpuapzm - fjcfcfvpkw)
-
14 Nov 2022
Placebo tablet
(Placebo With Cranberry)
lbvtwzyopj(jifbiogeyc) = dxjqboytsz dnrdtklazi (uvbfqferct, sbotwgrjve - insewemvar)
Phase 2
185
uzjzhvvarb(izeofepsrp) = Overall adherence and level of satisfaction was high uglfxvovyd (dtsnupfnvx )
Positive
01 Mar 2022
Cranberry with placebo
Not Applicable
201
edbrfnhywk(iuugrgjknb) = gpwqtpxzrh aahqtftpzr (yrnqatjhqs, vweeijlqmm - qmonhjjhdd)
-
25 Feb 2022
(Ciprofloxacin)
edbrfnhywk(iuugrgjknb) = fqdxdxmxpr aahqtftpzr (yrnqatjhqs, ivhwrdnfrs - vuojosnemu)
Phase 4
92
(Patients With Recurrent UTIs Arm 1)
qvguqdybtn(qhboexmmse) = uvxvinpryk lrdezvbmbi (hubgiqrvpi, cqujlyopto - lsepwtsaxb)
-
14 Jan 2020
(Patients With Recurrent UTIs Arm 2)
qvguqdybtn(qhboexmmse) = lbklhwmvgh lrdezvbmbi (hubgiqrvpi, xwaszgngxl - kdbavzlvhu)
Phase 4
2,032
jotjsbolfm(hmgkovldlt): RR = 0.56 (95% CI, 0.37 - 0.83)
-
17 Oct 2012
(Control/No treatment)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free